+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
MKPL

M K Proteins Share Price

 
51.53% Fall from 52W High

 

M K Proteins live price: ₹4.29. It opened at ₹5 vs previous close ₹5; intraday high/low: ₹5/₹4. The 50 & 200 DMA stand at ₹4.80/₹5.60.

M K Proteins Performance

  • Today's Low
  • ₹4
  • Today's High
  • ₹5
  • 52 Week Low
  • ₹4
  • 52 Week High
  • ₹9
  • Open Price₹5
  • Previous Close₹5
  • Volume665,377
  • 50 DMA₹4.80
  • 100 DMA₹5.00
  • 200 DMA₹5.60

M K Proteins Chart

Investment Returns

  • Over 1 Month -12.63%
  • Over 3 Month -19.66%
  • Over 6 Month -18.29%
  • Over 1 Year -40.99%

Smart Investing Starts Here Start SIP with M K Proteins for Steady Growth!

Invest Now

M K Proteins Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 23.6
  • PEG Ratio
  • -1.3
  • Market Cap Cr
  • 161
  • P/B Ratio
  • 2.1
  • Average True Range
  • 0.2
  • EPS
  • 0.2
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.1
  • RSI
  • 26.67
  • MFI
  • 26.64

Latest Stock News Updates

M. K. Proteins Ltd - 543919 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulation, 2018, we are submitting herewith copy of Certificate issued by M/s Big Share Services Private Limited bearing SEBI Registration No INR000001385, Registrar and Share Transfer Agent (RTA) of the Company for the quarter ended June 30, 2026.

M. K. Proteins Ltd - 543919 - Closure of Trading Window

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for transactions in Shares of the Company for all the Employees, Directors, Key Managerial Personnel, Promoters, designated persons and their immediate relatives or any other insider shall remain closed from Wednesday, 1st July, 2026 till end of 48 hours after the declaration of Un-Audited Financial Results of the Company for the First Quarter ended 30th June, 2026.

M. K. Proteins Ltd - 543919 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting the copies of Newspaper publications in the Financial Express (English Edition) and Jansatta (Hindi Edition) regarding the Audited Financial Results of the Company for the quarter and year ended March 31, 2026

M K Proteins Financials

M K Proteins Technicals

EMA & SMA

Current Price
₹4.29
-0.19 (-4.24%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹4.60
  • 50 Day
  • ₹4.80
  • 100 Day
  • ₹5.00
  • 200 Day
  • ₹5.60

Resistance and Support

4.36 Pivot Speed
  • R3 4.90
  • R2 4.70
  • R1 4.50
  • S1 4.10
  • S2 4.00
  • S3 3.80

M K Proteins Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-14 Quarterly Results
2025-08-12 Quarterly Results & Others To consider other business matters.
2025-05-23 Audited Results
Date Purpose Remarks
2023-11-10 Split Stock split from Rs. 10/- to Re. 1/-.
Date Purpose Remarks
2024-03-15 Bonus Bonus issue in the ratio of 2:1 of Re. 1/-.
2023-02-03 Bonus Bonus issue in the ratio of 2:1 of Rs. 10/-.

M K Proteins Shareholding Pattern

74.82%
25.18%
0%

M K Proteins FAQs

M K Proteins share price is ₹4 As on 21 July, 2026 | 01:28

The Market Cap of M K Proteins is ₹161 Cr As on 21 July, 2026 | 01:28

The P/E ratio of M K Proteins is 23.6 As on 21 July, 2026 | 01:28

The PB ratio of M K Proteins is 2.1 As on 21 July, 2026 | 01:28

The 52 week High & Low of M K Proteins is ₹8.8/₹3.6 respectively As on 21 July, 2026 | 01:28

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23